- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Primedex to explore strategic options
California imaging services provider Primedex announced last monththat it is exploring new options for the company, including possiblepartnerships or alliances. The announcement came as no great surprise, given recent Primedexhistory and the general
California imaging services provider Primedex announced last monththat it is exploring new options for the company, including possiblepartnerships or alliances.
The announcement came as no great surprise, given recent Primedexhistory and the general popularity of mergers and acquisitionsin the imaging service sector. Primedex nearly acquired San Diego'sMedical Imaging Centers of America in July, only to lose out toan 11th-hour bid by U.S. Diagnostic Labs. USDL has a deal pendingto acquire MICA's 17 centers for about $32 million (SCAN 7/31/96).
A merger in May with Diagnostic Imaging Services brought 10Southern California imaging centers, 15 ultrasound labs, and 13mobile ultrasound units into the Primedex fold. Before that deal,Los Angeles-based Primedex operated 19 California imaging centersthrough its RadNet subsidiary. Its Future Diagnostics subsidiaryarranges brokered imaging services for 180 imaging centers inthe state.
In a statement, Primedex president and CEO Dr. Howard Bergersaid that his company's board of directors had determined thatthe time is right to explore alternatives to enhance the company'svalue and position. He declined to elaborate on the announcementwhen contacted by SCAN.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
